Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling - Zak, M; Hanan, E J; Lupardus, P (Bioorganic & medicinal chemistry letters, 2019)
et al.